# 119-s-5258: PREFERRED Screening Act 119-s-5258, PREFERRED Screening Act, is a 119th Congress bill sponsored by Sen. Cassidy, Bill [R-LA] (R-LA); status introduced; PRIA reads it as touching household money (as of 2026-08-20). - Canonical: https://policyrisk.com/legislation/119-s-5258 - As of: 2026-08-20 - Plain-text twin of the page above; the HTML and this file carry the same facts. ## Facts - Bill: 119-s-5258 - Congress: 119 - Title: PREFERRED Screening Act - Status: introduced - Introduced: 2026-08-05 - Sponsor: Sen. Cassidy, Bill [R-LA] (R-LA) - Cosponsors: 1 - Policy area: Health - Touches household money: yes - Last recorded action: 2026-08-20 ## Summary **Personalized risk‑based breast cancer screening for Medicare beneficiaries** would create a 7‑year demonstration to pay providers for comprehensive breast cancer risk assessments and tailored screening and risk‑reduction plans. - Medicare beneficiaries age 40–74 enrolled in Part A or Part B but not Medicare Advantage would be eligible for assessments that combine multigene panel results, polygenic risk scores, breast density, family history, and clinical and lifestyle factors to assign risk categories and produce a personalized screening and risk‑reduction plan. - Eligible providers such as physicians, nurse practitioners, physician assistants, certified nurse‑midwives, and genetic counselors would be reimbursed for assessment and plan development with payments informed by clinical time, complexity, genetic interpretation, and alignment with the physician fee schedule. Laboratories that submit de‑identified genomic variant data to ClinVar get selection priority. - The Model would begin on the date the first eligible person receives an assessment, must start within 2 years or trigger notification of delay, and run for 7 years. The Secretary would evaluate access, screening patterns by risk, MRI and endocrine therapy use, 10‑ and 20‑year cost‑effectiveness, and cancer stage at detection to inform adjustments and possible expansion to Medicare Advantage. ## Cosponsors (1) - Sen. Murkowski, Lisa [R-AK] (R-AK), 2026-08-05T00:00:00.000Z ## Provisions PRIA read - Evaluation, reports, and expansion review: benefit, medium. If enacted, CMS would evaluate the Model using many measures like assessment uptake, whether planned services were furnished, MRI use for high-risk people, use of endocrine prevention medicines, and cost-effectiveness over 10 and 20 years. CMS must give an interim report within 3 years of Model sta… - Personalized screening and plans: benefit, medium. If enacted, the Model would require personalized screening and risk-reduction plans based on risk level. Plans would recommend screening frequency and imaging types, refer high-risk people for breast MRI, offer counseling on modifiable risks and on endocrine prevention medicines, refer for genetic… - What a risk check must include: benefit, medium. If enacted, assessments under the Model would have to collect genetic panel results (including BRCA1, BRCA2, PALB2, CDH1, TP53, PTEN, STK11, ATM, CHEK2 and others CMS picks), polygenic risk scores, family history, breast density, clinical and lifestyle risk factors, and other relevant items. CMS wo… - Who can deliver assessments locally: benefit, medium. If enacted, many clinicians would be eligible to get paid for providing assessments and plans. That would include doctors, nurse practitioners, physician assistants, certified genetic counselors, midwives, and others CMS approves. The Model would let providers deliver services in person or remotely… - Labs must share genetic variants: benefit, low. If enacted, CMS could favor providers who use labs that submit de-identified variant data, including variants of uncertain significance, to the ClinVar public database. The Model’s interim and final reports must show the rate of labs used by providers that submit such variant data to ClinVar. - Payments for assessments and plans: benefit, low. If enacted, the Secretary would set a payment amount to reimburse clinicians for providing the full risk assessment and personalized plan. CMS must consider clinical time, complexity, interpretation of genetic and polygenic results and breast density, and time to develop plans. CMS could adjust the… - New Medicare breast-risk model: mixed, medium. If enacted, the bill would create a time-limited Medicare payment model to pay providers for comprehensive breast cancer risk assessments and personalized screening plans. The Secretary must start the Model within 2 years of enactment and the Model would end 7 years after it begins. No new appropri… - Who is eligible for checks: mixed, medium. If enacted, the Model would apply only to people on Medicare Part A or Part B who are not in Medicare Advantage (Part C). You would need to be age 40 through 74 and not receiving hospice or dialysis for end-stage renal disease. The Model would start when the first eligible person gets a covered com… ## Related bills - 119-s-4744: Take Care of America’s Veterans Act - 119-s-2120: Older Americans Act Reauthorization Act of 2025 - 119-s-2121: SUPPORT for Patients and Communities Reauthorization Act of 2025 - 119-s-1748: Kids Online Safety Act - 119-s-93: Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2025 - 119-s-3257: John A. Hauser Mental Health in Aviation Act ## Sources - [119-s-5258 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/5258) ## Related - [119-s-4744: Take Care of America’s Veterans Act](https://policyrisk.com/legislation/119-s-4744) - [119-s-2120: Older Americans Act Reauthorization Act of 2025](https://policyrisk.com/legislation/119-s-2120) - [119-s-2121: SUPPORT for Patients and Communities Reauthorization Act of 2025](https://policyrisk.com/legislation/119-s-2121) - [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748) - [119-s-93: Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2025](https://policyrisk.com/legislation/119-s-93) - [119-s-3257: John A. Hauser Mental Health in Aviation Act](https://policyrisk.com/legislation/119-s-3257) - [All bills in Congress](https://policyrisk.com/legislation) Source: PRIA, https://policyrisk.com/legislation/119-s-5258 (as of 2026-08-20).